P45
siRNA CAPSULON Technology: Redefined siRNA Transfection
I Tarakanchikova(1) I Ochigava(1) M Voglstätter(1) I Hanemann(1) A Pohl(1) I Nazarenko(2)
1:CapCoBIO GmbH; 2:Institute for Infection Prevention and Hospital Epidemiology, Medical Center - University of Freiburg
The application of RNA interference (RNAi) in mammalian cells has brought about a paradigm shift in the field of functional genomics. This breakthrough enables scientists to manipulate gene expression with remarkable simplicity, efficiency, and precision within mammalian cells. Such a capability holds immense promise for driving scientific discoveries, commercial applications, and therapeutic innovations.
To ensure the successful attenuation of gene expression, the proficient transfection of small interfering RNA (siRNA) stands as a critical requirement, underscoring its pivotal role in achieving effective gene silencing outcomes.
The CAPSULON Technology developed by CapCoBIO GmbH empowers researchers with the ability to achieve remarkably effective siRNA transfection at varying concentrations, spanning from low to high. This flexibility grants researchers to select their preferred siRNA concentration for experimentation.
siRNA CAPSULON Kit is a straightforward and easy workflow for siRNA delivery with biodegradable polymer nanocapsules.
Key Features:
Highly efficient: siRNA delivery without cytotoxic effects and off-target effects.
Cost effective: low amounts of siRNA generate high knock-down effects.
Versatile: applicable with any culture medium. No medium change needed.
Fast and easy: streamlined three step protocol.
